hhs

Full Text of 2018 HHS Letter to DEA Rescinding Kratom Ban Recommendation

DEPARTMENT OF HEALTH AND HUMAN SERVICESOffice of the SecretaryOffice of the Assistant Secretary for HealthWashington, D.C. 20201 AUG 16 2018 [stamped] The Honorable Uttam DhillonActing AdministratorDrug Enforcement AdministrationU.S. Department of Justice8701 Morrissette DriveSpringfield, VA 22152 Dear Mr. Dhillon: Pursuant to the Controlled Substances Act (CSA), 21 U.S.C. ยง 811, I am rescinding our prior recommendation …

Full Text of 2018 HHS Letter to DEA Rescinding Kratom Ban Recommendation Read More »

FDA Head Ranted About Kratom on Twitter a Day After HHS Quietly Withdrew Ban Recommendation

On August 16, 2018, Brett Giroir, Assistant Secretary of Health for the Department of Health and Human Services (HHS) sent a letter to then Acting Administrator of the Drug Enforcement Administration (DEA), Uttam Dhillon, rescinding a previous HHS recommendation that kratom should be federally outlawed. Pursuant to the Controlled Substances Act…, I am rescinding our …

FDA Head Ranted About Kratom on Twitter a Day After HHS Quietly Withdrew Ban Recommendation Read More »

Federal Actions on Kratom: 2006 to 2018 HHS Decision to Withhold Ban

This is a timeline of actions taken by federal agencies concerning kratom up to the August 16, 2018 HHS decision to withdraw a recommendation to ban kratom. FDA has been the most active federal agency in trying to control kratom, from releasing several import alerts, to requesting shipment seizures, to sending cease and desist letters …

Federal Actions on Kratom: 2006 to 2018 HHS Decision to Withhold Ban Read More »

Good News for Kratom Science: House Committee on Appropriations requests expanded research; NIDA grants $3.4 million to UF College of Pharmacy

Slowly but surely, government is responding to the relentless advocacy of the kratom community and the American Kratom Association. In addition to the state governments of Georgia, Utah, and Arizona (that recently decided to regulate rather than ban kratom), the House of Representatives and the National Institutes on Drug Abuse are listening to our calls …

Good News for Kratom Science: House Committee on Appropriations requests expanded research; NIDA grants $3.4 million to UF College of Pharmacy Read More »

Scientists’ Letter to HHS, DEA, FDA, NIDA questions FDA’s handling of Kratom

An open letter to HHS, DEA, NIDA, and FDA signed by twelve leading scientists from various fields has been posted on the website of American Kratom Association. The 33 page letter analyzes and sharply criticizes, piece by piece, the FDA’s 8-Factor Analysis that led the organization to determine that kratom should be placed on the …

Scientists’ Letter to HHS, DEA, FDA, NIDA questions FDA’s handling of Kratom Read More »